<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shaaban KA</submitter><funding>NCI NIH HHS</funding><pagination>141-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3030652</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(1)</volume><pubmed_abstract>Four new angucyclin(on)es, 11-deoxylandomycinone (1) and landomycins X-Z (2-4) were isolated from the crude extract of Streptomyces cyanogenus K62 mutant strain, along with the recently reported landomycins S, T and V (5-7) and five other known compounds. The structures of the new compounds 1-4 were elucidated by 1D and 2D NMR studies along with HR-MS analyses. Unique about the structures is that the fourth sugar moiety (sugar D) in landomycins X-Z (2-4) was β-D-amicetose instead of β-D-olivose, usually found in this position. The new angucyclin(on)es were biologically evaluated in comparison with previously known congeners against a small panel of MCF-7 (estrogen responsive) and MDA 231 (estrogen refractory) breast cancer cell lines. 11-deoxylandomycinone (IC(50) 2.1 ± 0.3 and 1.2 ± 0.4 μ</pubmed_abstract><journal>The Journal of antibiotics</journal><pubmed_title>11-Deoxylandomycinone and landomycins X-Z, new cytotoxic angucyclin(on)es from a Streptomyces cyanogenus K62 mutant strain.</pubmed_title><pmcid>PMC3030652</pmcid><funding_grant_id>R01 CA102102-05S1</funding_grant_id><funding_grant_id>CA 102102</funding_grant_id><funding_grant_id>R01 CA102102</funding_grant_id><funding_grant_id>R01 CA102102-05</funding_grant_id><pubmed_authors>Shaaban KA</pubmed_authors><pubmed_authors>Damodaran C</pubmed_authors><pubmed_authors>Rohr J</pubmed_authors><pubmed_authors>Stamatkin C</pubmed_authors></additional><is_claimable>false</is_claimable><name>11-Deoxylandomycinone and landomycins X-Z, new cytotoxic angucyclin(on)es from a Streptomyces cyanogenus K62 mutant strain.</name><description>Four new angucyclin(on)es, 11-deoxylandomycinone (1) and landomycins X-Z (2-4) were isolated from the crude extract of Streptomyces cyanogenus K62 mutant strain, along with the recently reported landomycins S, T and V (5-7) and five other known compounds. The structures of the new compounds 1-4 were elucidated by 1D and 2D NMR studies along with HR-MS analyses. Unique about the structures is that the fourth sugar moiety (sugar D) in landomycins X-Z (2-4) was β-D-amicetose instead of β-D-olivose, usually found in this position. The new angucyclin(on)es were biologically evaluated in comparison with previously known congeners against a small panel of MCF-7 (estrogen responsive) and MDA 231 (estrogen refractory) breast cancer cell lines. 11-deoxylandomycinone (IC(50) 2.1 ± 0.3 and 1.2 ± 0.4 μ</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Jan</publication><modification>2025-04-04T19:42:55.884Z</modification><creation>2019-03-27T00:38:31Z</creation></dates><accession>S-EPMC3030652</accession><cross_references><pubmed>20978514</pubmed><doi>10.1038/ja.2010.121</doi></cross_references></HashMap>